BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vaccinex, Inc. 

1895 Mt. Hope Avenue

Rochester  New York  14620  U.S.A.
Phone: 585-271-2700 Fax: 585-271-2766


SEARCH JOBS




Industry
Biotechnology






 Company News
Vaccinex, Inc. Provides An Update On Its VX15/2503 Phase 1 Clinical Trial In Multiple Sclerosis Patients 3/31/2015 12:11:20 PM
Vaccinex, Inc. Signs Multi-Target Antibody Discovery Deal With Five Prime Therapeutics, Inc. (FPRX) 3/20/2015 7:11:10 AM
Vaccinex, Inc. Announces The Publication Of Data Demonstrating Preclinical Efficacy In An Animal Model Of Huntington Disease 2/18/2015 7:41:54 AM
Vaccinex, Inc. Announces Groundbreaking Preclinical Data Demonstrating An Immunomodulatory Role For Anti-SEMA4D Antibody Blockade In Colon And Breast Cancer 1/27/2015 9:55:14 AM
Vaccinex, Inc. Announces Publication Of Preclinical Studies With An Anti-SEMA4D Antibody In Animal Models Of Neuroinflammatory And Demyelinating Disease 12/12/2014 8:26:09 AM
Vaccinex, Inc. Provides An Update On Its VX15/2503 Phase 1 Clinical Trial In Cancer Patients 12/9/2014 9:02:02 AM
Vaccinex, Inc. To Present Its ActivMAb Antibody Discovery Technology At The 2014 IBC Antibody Engineering & Therapeutics Conference 12/5/2014 12:47:15 PM
Vaccinex, Inc. And Janssen Enter Into A Collaboration For The Creation Of Novel Anti-Cancer Agents 12/2/2014 12:58:14 PM
Vaccinex, Inc. Announces Initiation of a Phase 1 Clinical Trial of VX15/2503 Antibody in Multiple Sclerosis Patients 1/7/2013 11:20:09 AM
Vaccinex, Inc. Initiates Phase I Clinical Trial of Novel Therapeutic Antibody in Cancer Patients With Advanced Solid Tumors 1/4/2011 6:21:48 AM
123